ELOVL4 and neoplasm: Furthermore, in vitro and in vivo mouse experiments from 2023 show that the NOTCH-RIPK4-IRF6-ELOVL4 signaling axis acts as a potent tumor suppressor in squamous cell carcinomas [26].